Diana M. Gibb
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 240 publications
Pharmacokinetic modeling to support WHO-weight band dosing of a new pediatric darunavir/ritonavir (120/20 mg) fixed-dose combination tablet for children at least 3 years old and weighing 10 to less than 35 kg.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: August 21, 2026
Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV.
Journal: Antimicrobial agents and chemotherapy
Published: July 17, 2026
Intravenous Artesunate in Artemisinin-Resistant Severe Malaria in Uganda.
Journal: The New England journal of medicine
Published: June 03, 2026
Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial.
Journal: The Pediatric infectious disease journal
Published: February 24, 2026
Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.
Journal: Open forum infectious diseases
Published: January 26, 2026
The Utility of a Three-gene Host Response to Discriminate Tuberculous Meningitis From Other Infections in Children.
Journal: The Pediatric infectious disease journal
Published: December 23, 2025
Correction: Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.
Journal: PloS one
Published: December 16, 2025
Computer-aided detection for radiological disease severity classification on chest radiograph in children with intra-thoracic tuberculosis.
Journal: PLOS global public health
Published: November 02, 2025
Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 16, 2025
Predictors of treatment failure in children living with HIV starting first-line antiretroviral therapy in the ODYSSEY trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: October 16, 2025
Population pharmacokinetics of ritonavir as a booster of lopinavir, atazanavir, or darunavir in African children with HIV.
Journal: Antimicrobial agents and chemotherapy
Published: September 26, 2025
CMV viraemia is associated with mortality among children with HIV starting antiretroviral therapy in sub-Saharan Africa.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 21, 2025
Last Updated: 09/26/2026